As of today (2024-04-23), Hangzhou Tigermed Consulting Co's share price is ¥53.09.
Hangzhou Tigermed Consulting Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ¥1.33. Hence, Hangzhou Tigermed Consulting Co's Price-to-Operating-Cash-Flow Ratio for today is 39.95.
The historical rank and industry rank for Hangzhou Tigermed Consulting Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
SZSE:300347'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 28.99 Med: 88.02 Max: 302.29
Current: 39.65
During the past 13 years, Hangzhou Tigermed Consulting Co's highest Price-to-Operating-Cash-Flow Ratio was 302.29. The lowest was 28.99. And the median was 88.02.
Hangzhou Tigermed Consulting Co's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was ¥0.55.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ¥1.33.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Hangzhou Tigermed Consulting Co was -15.40% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 2.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 18.30% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 35.50% per year.
During the past 13 years, Hangzhou Tigermed Consulting Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 116.70% per year. The lowest was -19.70% per year. And the median was 32.20% per year.
Hangzhou Tigermed Consulting Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Hangzhou Tigermed Consulting Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Hangzhou Tigermed Consulting Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
89.19 |
129.29 |
78.17 |
66.75 |
41.36 |
|
Hangzhou Tigermed Consulting Co Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
66.75 |
76.51 |
40.67 |
48.05 |
41.36 |
Competitive Comparison
For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Tigermed Consulting Co Price-to-Operating-Cash-Flow Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Hangzhou Tigermed Consulting Co's Price-to-Operating-Cash-Flow falls into.
Hangzhou Tigermed Consulting Co Price-to-Operating-Cash-Flow Calculation
Hangzhou Tigermed Consulting Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 53.09 | / | 1.329 |
| = | 39.95 |
Hangzhou Tigermed Consulting Co's Share Price of today is ¥53.09.
Hangzhou Tigermed Consulting Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.33.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description
Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300347 has been successfully added to your